Safety Study of ARO Spinal System as an Adjunct to Lumbar Decompression

January 13, 2015 updated by: ARO Medical

Temporary Axial Rotation Stabilization for Lumbar Disc Prolapse Surgery With the ARO® Spinal System: A Non-randomized Prospective Analysis of Clinical Efficacy, Safety and Cost Effectiveness

To evaluate the clinical safety and effectiveness of the ARO Spinal System and to assess preliminary cost/benefit analysis in patients undergoing decompression surgery for symptomatic lumbar disc herniations.

The general hypothesis is that the ARO significantly improves outcomes in patients undergoing decompression surgery for symptomatic lumbar disc herniations.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Not provided

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark, Dk-8000
        • Aarhus University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Radicular pain and evidence of nerve-root irritation lasting 6 weeks or more as evidenced by both:

    1. Radicular pain - below the knee,
    2. Nerve root irritation

    i. positive nerve root tension sign - straight leg raise positive between 30 and 70 degrees, or ii. positive femoral tension sign, or iii. neurologic deficit - asymmetrical depressed reflex or decreased sensation in a dermatomal distribution or weakness in a myotomal distribution.

  2. Primary one-level posterolateral herniation in the lower lumbar spine (L4-L5 or L5-S1 only) as shown by magnetic resonance (MR) imaging (protrusion, extrusion or sequestered fragment) consistent with the clinical symptoms (both level and side).
  3. The investigator confirms that the patient is a surgical candidate for discectomy,
  4. The patient has been scheduled for their surgical procedure no more than two months from time of consent,
  5. 18 years to 55 years of age at time of consent,
  6. Willing to complete the study requirements and permit agency and sponsor authorized personnel to access medical records,
  7. Able to understand oral and written Danish.

Exclusion Criteria:

  1. Previous lumbar surgery
  2. Cauda equine syndrome
  3. Scoliosis greater than 15 degrees
  4. Osteoporosis
  5. Segmental instability (> 10 degrees angular motion or >4mm translation)
  6. Vertebral fractures
  7. Spinal Infections
  8. Spinal tumors
  9. Inflammatory spondyloarthropathy
  10. Pregnancy or the intent to become pregnant in the following year
  11. Comorbid conditions contraindicating surgery
  12. Multiple herniations
  13. Known allergy to titanium, aluminum or vanadium
  14. Female patients of childbearing age, who are not willing to use adequate contraception specified as: intrauterine devices, hormonal contraceptives (contraceptive pills, implants, transdermal patches, hormonal vaginal devices or injections with prolonged release). It is accepted in certain cases to include subjects having a sterilized permanent partner or subjects using double barrier contraceptive methods which is a condom combined with a diaphragm.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ARO Spinal System
The device provides an internal axial rotation orthosis (ARO) for patients being surgically treated for herniated nucleus pulposus (HNP).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Safety profile compared to historical controls and improvement in leg and back pain
Time Frame: One year
One year

Secondary Outcome Measures

Outcome Measure
Time Frame
Oswestry Disability Index (ODI) improvement is superior to historical control
Time Frame: 1 year
1 year
VAS back pain improvement is superior to historical control
Time Frame: 1 year
1 year
VAS leg pain improvement is superior to historical control,
Time Frame: 1 year
1 year

Other Outcome Measures

Outcome Measure
Time Frame
The percentage of patients very or somewhat satisfied with their symptoms is greater than historical control
Time Frame: 1 year
1 year
There is an increase in the percentage of patients with evidence of annular healing in comparison to historical control
Time Frame: 1 year
1 year
There is a decrease in the percentage of patients with evidence of facet degenerative changes in comparison to historical control
Time Frame: 1 year
1 year
There is a reduction in the percentage of patients with degenerative changes in the disc in comparison to historical control
Time Frame: 1 year
1 year
There is a reduction in the axial rotation motion on the operative level compared to pre-operative motion
Time Frame: 1 year
1 year
Surgery with the device has no neurological impact
Time Frame: 1 year
1 year
The rate of reherniation is less than in historical control
Time Frame: 1 year
1 year
The percent of patients disabled at one year is less than in historical controls
Time Frame: 1 year
1 year
The device has a neutral cost/benefit profile in comparison to historical controls to permit further clinical study
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Cody Bunger, MD, DrMedSc, Aarhus University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Anticipated)

July 1, 2015

Study Completion (Anticipated)

July 1, 2015

Study Registration Dates

First Submitted

October 23, 2013

First Submitted That Met QC Criteria

October 23, 2013

First Posted (Estimate)

October 28, 2013

Study Record Updates

Last Update Posted (Estimate)

January 14, 2015

Last Update Submitted That Met QC Criteria

January 13, 2015

Last Verified

January 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbar Disc Prolapse With Radiculopathy

Clinical Trials on ARO Spinal System

3
Subscribe